Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Cells. 1990 Aug-Sep;2(8-9):275-80.

Activation of programmed cell death by anticancer agents: cisplatin as a model system.

Author information

  • 1Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire 03756.


The anticancer drug cisplatin exerts its action as a consequence of interaction with DNA. Cell cycle progression facilitates sensitivity to the drug, but inhibition of DNA synthesis is not necessarily the critical step. Lethally damaged cells can progress to and arrest for several days in the G2 phase of the cell cycle before dying. Certain features of cisplatin-induced cell death, such as chromatin condensation and the activation of a DNA endonuclease, are reminiscent of apoptosis, or programmed cell death. Many other anticancer drugs produce the same phenotypic effects, suggesting that these agents may all interact with the same signal transduction pathway leading to cell death.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk